| FORM 4 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
| Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). | |||||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Issuer Name and Ticker or Trading Symbol
UNITEDHEALTH GROUP INC [ UNH ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
||||||||||||||||||||||||
|
3. Date of Earliest Transaction
(Month/Day/Year) 02/16/2024 | ||||||||||||||||||||||||||
|
4. If Amendment, Date of Original Filed
(Month/Day/Year) |
6. Individual or Joint/Group Filing (Check Applicable Line)
|
| Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 02/16/2024 | M | 6,535 | A | $160.31 | 38,162.688 | D | |||
| Common Stock | 02/16/2024 | F | 4,074 | D | $521.07 | 34,088.688 | D | |||
| Common Stock | 02/16/2024 | M | 17,681 | A | $226.64 | 51,769.688 | D | |||
| Common Stock | 02/16/2024 | F | 12,246 | D | $521.13 | 39,523.688 | D | |||
| Common Stock | 02/16/2024 | M | 21,377 | A | $262.98 | 60,900.688 | D | |||
| Common Stock | 02/16/2024 | F | 15,616 | D | $521.24 | 45,284.688 | D | |||
| Common Stock | 02/16/2024 | M | 13,008 | A | $243.2 | 58,292.688 | D | |||
| Common Stock | 02/16/2024 | F | 9,234 | D | $521.175 | 49,058.688 | D | |||
| Common Stock | 02/16/2024 | M | 23,747 | A | $302.2 | 72,805.688 | D | |||
| Common Stock | 02/16/2024 | F | 18,320 | D | $521.18 | 54,485.688 | D | |||
| Common Stock | 02/16/2024 | S | 28,943 | D | $521(1) | 25,542.688 | D | |||
|
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Non-Qualified Stock Options (right to buy) | $160.31 | 02/16/2024 | M | 6,535 | (2) | 02/08/2027 | Common Stock | 6,535 | $0 | 0 | D | ||||
| Non-Qualified Stock Options (right to buy) | $226.64 | 02/16/2024 | M | 17,681 | (3) | 02/13/2028 | Common Stock | 17,681 | $0 | 0 | D | ||||
| Non-Qualified Stock Options (right to buy) | $262.98 | 02/16/2024 | M | 21,377 | (4) | 02/26/2029 | Common Stock | 21,377 | $0 | 0 | D | ||||
| Non-Qualified Stock Options (right to buy) | $243.2 | 02/16/2024 | M | 13,008 | (5) | 08/12/2029 | Common Stock | 13,008 | $0 | 0 | D | ||||
| Non-Qualified Stock Options (right to buy) | $302.2 | 02/16/2024 | M | 23,747 | (6) | 02/13/2030 | Common Stock | 23,747 | $0 | 0 | D | ||||
| Explanation of Responses: |
| 1. This transaction was executed in multiple trades ranging from $520.320 to $522.420 per share. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected. |
| 2. The non-qualified stock options vested at a rate of 25% annually on February 8 from the years 2018 through 2021. |
| 3. The non-qualified stock options vested at a rate of 25% annually on February 13 from the years 2019 through 2022. |
| 4. The non-qualified stock options vested at a rate of 25% annually on February 26 from the years 2020 through 2023. |
| 5. The non-qualified stock options vested at a rate of 25% annually on August 12 from the years 2020 through 2023. |
| 6. The non-qualified stock options vested at a rate of 25% annually on February 13 from the years 2021 through 2024. |
| Remarks: |
| Faraz A. Choudhry, Attorney-in-Fact for Brian R. Thompson | 02/20/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||